Business Context and Reporting Period
Company: SkinHealth Systems Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 5, 2026
Reporting Period: Event date May 5, 2026
This filing reports the termination of the Company's Chief Revenue Officer, Mr. Ronald Menezes, effective May 5, 2026. The termination was without cause and not related to any disagreement regarding financial reporting or operations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial performance data.
Material Changes
- Executive Departure: Mr. Ronald Menezes was terminated as Chief Revenue Officer effective May 5, 2026.
- Separation Agreement: The Company intends to enter into a separation agreement to document applicable payments or benefits. As of the filing date, no material terms have been determined, and negotiations are ongoing.
Guidance, Outlook, and Risks
Management Commentary: The Board confirmed the termination was without cause and unrelated to financial or operational disputes.
Contingencies: The Company will file an amendment to this Current Report within four business days after entering into a definitive separation agreement to disclose material terms.
Risks: The filing does not explicitly list new risks, though the departure of a C-suite executive may impact revenue operations until a replacement is secured.
Investor Verification Checklist
- Monitor for the upcoming amendment to this 8-K detailing the specific terms of Mr. Menezes' separation agreement.
- Verify if the Company has announced an interim replacement or a search for a new Chief Revenue Officer.
- Review subsequent filings for any impact on the Company's revenue strategy or sales pipeline following this departure.